26 octobre, 2006 01:43

The three panel members who should have been in conflict sitting on health Canada's panel are:

Harold J. Brandon

Served as consult at FDA advisory panel hearing on silicone breast implants licensing applications. Received funding from manufacturers for research and consulting.

Michael a. Brook

Answered questions as an Inamed paid consultant, from the FDA Panel on Breast Implants (APRIL 2005) about platinum in silicones, based on chemical literature. Made no statements declaring support of, or opposition to, licensing of silicone gel filled breast implants.

Acted as independent expert, to advice Inamed with regard to their pre market approval applications for silicone gel filled implants to the U.S.FDA on several occasions since 2003.

Submitted a paper, currently under review, entitled platinum in silicone breast implants. That discusses the chemistry of platinum as described in the scientific literature.

Mitchell Brown

Received portion of the travel and hotel expenses from manufacturers for speaking engagements and training of surgeons in the use of cohesive gel breast implants 2003, 2004, and 2005. Currently preparing a paper on his clinical experience with patients with cohesive gel breast implants.